Nancy Hamzo

Nancy's practice focuses extensively on advising multinational clients with the planning and implementation of complex mergers and acquisitions, multi-jurisdictional corporate reorganizations, including pre-transaction restructurings, post-acquisition integrations, carve-outs, spin-offs, entity rationalizations, expansions and other strategic transactions. She also routinely advises on antitrust/competition and foreign investment requirements in Canada.

Corporate Transactional

• Advised Brookfield Asset Management on the global aspects of its USD 1.7 billion acquisition of nVent Electric’s Thermal Management business.

• Advised Thomson Reuters on the global divestiture of majority interest in its Elite software business to TPG to create a new legal tech company with a value of USD 500 million.

• Advised Accenture on the acquisition and integration of Eclipse Automation, a provider of customized manufacturing automation and robotics solutions.

• Advised Mercedes-Benz Group AG on the sale of the corporate-owned Mercedes-Benz dealerships in the Greater Toronto Area to the AWIN Group of Dealerships and Zanchin Automotive Group.

• Advised Embracer Group, a Swedish headquartered video game holding company on multiple acquisitions in Canada, including the USD 300 million acquisition of Eidos, Crystal Dynamics, Square Enix Montreal and a catalogue of Intellectual Property; its approximately USD 105 million acquisition of A Thinking Ape Entertainment Ltd.; its acquisitions of IUGO Mobile Entertainment Inc. and The Gearbox Entertainment Company.

• Advised ACNielsen Company of Canada on its acquisition of Cornerstone Capabilities Inc. 

• Advised Enad Global 7, a Swedish headquartered online games developer on multiple acquisitions including the acquisitions of Big Blue Bubble Inc. and Piranha Games Inc.

• Advised Altimeter Growth Capital (Nasdaq: "AGC"), a special purpose acquisition company, as non-US counsel on its merger and plan to take Grab Holdings public in the US.

• Advised Affirm, Inc. on its acquisition of PayBright Inc. for total cash and equity consideration of CAD 340 million.

• Advised Brookfield Business Partners LP, the private equity arm of Brookfield Asset Management Inc. in the USD 230 million sale of BGRS to Relo Group.

• Advised Brookfield Business Partners LP, the private equity arm of Brookfield Asset Management Inc. on all non-US legal matters and implementation of its USD 13.2 billion acquisition of the Power Solutions business of Johnson Controls International.

• Represented Camso Inc. on its USD 1.7 billion sale to The Michelin Group. The transaction spanned over 28 jurisdictions.

• Advised a global biotechnology company on a post-acquisition integration matter involving over 70 jurisdictions.

• Advised Baxter International Inc. on the international aspects of the spinoff of its bioscience business into a new NYSE-listed company, Baxalta Incorporated.

• Advised on the Canadian legal implementation of the separation of Abbott Laboratories' research-based pharmaceuticals business which included the portfolio of proprietary pharmaceuticals and biologics into AbbVie Corporation.

Antitrust and Foreign Investment

• Advised Trillium Pharmaceutical, a clinical-stage blood cancer treatment company, on the Canadian merger control clearance in connection with its nearly USD 2.3 billion acquisition by pharmaceutical giant Pfizer Inc.

• Advised DIF Capital Partners on the Canadian foreign investment and merger control filings in connection with its acquisition, through DIF Infrastructure V, of BluEarth Renewables LP from Ontario Teachers' Pension Plan.

• Represented Camso Inc. on the merger control and foreign investment filings required in connection with its sale to The Michelin Group.

• Advised a state-owned enterprise on merger control, foreign investment and other regulatory approvals worldwide for its acquisition of control of the former Canadian monopoly grain marketing board through a joint venture with a US-based global agribusiness and food company.

• Advised Prestige Brands Inc. on the Canadian merger control aspects of its CAD 660 million acquisition of substantially all the North American OTC product portfolio of GlaxoSmithKline plc, through a competitive auction.

• Identified as a key lawyer in Legal 500 Canada 2021 for Corporate & M&A
• Identified as a key lawyer in Legal 500 Canada 2021 for Competition & Antitrust
• Identified as a key lawyer in Legal 500 Canada 2020 for Corporate & M&A
• Recognized as a Lexpert "Rising Star: Leading Lawyer Under 40" in Canada, 2017